Literature DB >> 1486896

Treatment of endocarditis due to penicillin-susceptible streptococci with a two-week course of ceftriaxone followed by oral amoxicillin.

J F García Rodríguez, J A Mesias Prego, D Domínguez Gómez.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1486896     DOI: 10.1007/bf01962384

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


× No keyword cloud information.
  5 in total

Review 1.  Antimicrobial treatment of infective endocarditis due to viridans streptococci, enterococci, and staphylococci.

Authors:  A L Bisno; W E Dismukes; D T Durack; E L Kaplan; A W Karchmer; D Kaye; S H Rahimtoola; M A Sande; J P Sanford; C Watanakunakorn
Journal:  JAMA       Date:  1989-03-10       Impact factor: 56.272

2.  Ceftriaxone sodium therapy of penicillin G-susceptible streptococcal endocarditis.

Authors:  W R Wilson
Journal:  JAMA       Date:  1992-01-08       Impact factor: 56.272

3.  Treatment of streptococcal endocarditis with a single daily dose of ceftriaxone sodium for 4 weeks. Efficacy and outpatient treatment feasibility.

Authors:  P Francioli; J Etienne; R Hoigné; J P Thys; A Gerber
Journal:  JAMA       Date:  1992-01-08       Impact factor: 56.272

4.  Antibiotic management of outpatients with endocarditis due to penicillin-susceptible streptococci.

Authors:  D Stamboulian; P Bonvehi; C Arevalo; R Bologna; I Cassetti; V Scilingo; E Efron
Journal:  Rev Infect Dis       Date:  1991 Jan-Feb

5.  Single daily dose treatment of severe refractory infections with ceftriaxone. Cost savings and possible parenteral outpatient treatment.

Authors:  J D Baumgartner; M P Glauser
Journal:  Arch Intern Med       Date:  1983-10
  5 in total
  1 in total

1.  Effect of gentamicin dosing interval on efficacy of penicillin or ceftriaxone treatment of experimental endocarditis due to penicillin-susceptible, ceftriaxone-tolerant viridans group streptococci.

Authors:  C M Brandt; C B Warner; M S Rouse; J M Steckelberg; W R Wilson
Journal:  Antimicrob Agents Chemother       Date:  1996-12       Impact factor: 5.191

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.